Cargando…
Dimethyl fumarate eliminates differentially culturable Mycobacterium tuberculosis in an intranasal murine model of tuberculosis
Tuberculosis (TB) claims nearly 1.5 million lives annually. Current TB treatment requires a combination of several drugs administered for at least 6 months. Mycobacterium tuberculosis (Mtb), the causative agent of TB, can persist in infected humans and animals for decades. Moreover, during infection...
Autores principales: | Glenn, Sarah M., Turapov, Obolbek, Makarov, Vadim, Kell, Douglas B., Mukamolova, Galina V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449328/ https://www.ncbi.nlm.nih.gov/pubmed/36093181 http://dx.doi.org/10.3389/fcimb.2022.957287 |
Ejemplares similares
-
Phenotypically Adapted Mycobacterium tuberculosis Populations from Sputum Are Tolerant to First-Line Drugs
por: Turapov, Obolbek, et al.
Publicado: (2016) -
Development of an In Vitro Assay for Detection of Drug-Induced Resuscitation-Promoting-Factor-Dependent Mycobacteria
por: Loraine, Jessica, et al.
Publicado: (2016) -
Two Faces of CwlM, an Essential PknB Substrate, in Mycobacterium tuberculosis
por: Turapov, Obolbek, et al.
Publicado: (2018) -
A Mycobacterium tuberculosis Effector Targets Mitochondrion, Controls Energy Metabolism, and Limits Cytochrome c Exit
por: Martin, Marianne, et al.
Publicado: (2023) -
Transcriptional Profile of Mycobacterium tuberculosis in an in vitro Model of Intraocular Tuberculosis
por: Abhishek, Sudhanshu, et al.
Publicado: (2018)